0.8(top 50%)
impact factor
40.5K(top 1%)
papers
383.7K(top 1%)
citations
201(top 1%)
h-index
0.8(top 50%)
impact factor
50.5K
all documents
398.0K
doc citations
295(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology20092,607
2Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiologyRadiotherapy and Oncology20061,387
3Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTVRadiotherapy and Oncology20051,315
4Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature reviewRadiotherapy and Oncology2003969
5Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiotherapy and Oncology2005867
6The relevance of tumour pH to the treatment of malignant diseaseRadiotherapy and Oncology1984858
7Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology1996795
8Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology1993762
9Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology1996710
10Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancerRadiotherapy and Oncology2011649
11Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology1992641
12CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelinesRadiotherapy and Oncology2003611
13The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis StudyRadiotherapy and Oncology1999607
14Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelinesRadiotherapy and Oncology2014585
15Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcomaRadiotherapy and Oncology2005583
16CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaRadiotherapy and Oncology2015576
17Oxygenation predicts radiation response and survival in patients with cervix cancerRadiotherapy and Oncology1998568
18Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)Radiotherapy and Oncology2010546
19Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour siteRadiotherapy and Oncology2011534
20Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancerRadiotherapy and Oncology1989528
21Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort studyRadiotherapy and Oncology2016527
22A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinomaRadiotherapy and Oncology2012525
23A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85Radiotherapy and Oncology1998523
24The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathwayRadiotherapy and Oncology2004519
25Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcomeRadiotherapy and Oncology1999518
26The radiotherapeutic injury – a complex ‘wound’Radiotherapy and Oncology2002518
27Pathogenetic mechanisms in radiation fibrosisRadiotherapy and Oncology2010498
28Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancerRadiotherapy and Oncology2000490
29Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancerRadiotherapy and Oncology2007475
30Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialRadiotherapy and Oncology1997474
31A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology1997469
32Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology2004469
33Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cellsRadiotherapy and Oncology2009463
34The radioresponsiveness of human tumours and the initial slope ofthe cell survival curveRadiotherapy and Oncology1984462
35ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancerRadiotherapy and Oncology2015462
36Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology1999461
37Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastasesRadiotherapy and Oncology1986460
38Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trialRadiotherapy and Oncology2005452
39Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicitiesRadiotherapy and Oncology2014451
40Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancerRadiotherapy and Oncology2012445
41MRI/linac integrationRadiotherapy and Oncology2008444
428 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working PartyRadiotherapy and Oncology1999427
43Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapyRadiotherapy and Oncology2007427
44Optimization of stationary and moving beam radiation therapy techniquesRadiotherapy and Oncology1988425
45CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelinesRadiotherapy and Oncology2015425
46Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trialsRadiotherapy and Oncology2013413
47Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/sRadiotherapy and Oncology2017410
48Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approachRadiotherapy and Oncology2013408
49Treatment of a first patient with FLASH-radiotherapyRadiotherapy and Oncology2019406
50Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysisRadiotherapy and Oncology2011404